Medpace Interest Expense vs Cost of Revenue Analysis

MEDP Stock

USD 376.26 4.26 1.15%

Medpace Holdings financial indicator trend analysis is infinitely more than just investigating Medpace Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medpace Holdings is a good investment. Please check the relationship between Medpace Holdings Interest Expense and its Cost Of Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Interest Expense vs Cost Of Revenue

Interest Expense vs Cost of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medpace Holdings Interest Expense account and Cost of Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Medpace Holdings' Interest Expense and Cost of Revenue is -0.7. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Cost of Revenue in the same time period over historical financial statements of Medpace Holdings, assuming nothing else is changed. The correlation between historical values of Medpace Holdings' Interest Expense and Cost of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Medpace Holdings are associated (or correlated) with its Cost of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost of Revenue has no effect on the direction of Interest Expense i.e., Medpace Holdings' Interest Expense and Cost of Revenue go up and down completely randomly.

Correlation Coefficient

-0.7

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Cost Of Revenue

Cost of Revenue is found on Medpace Holdings income statement and represents the costs associated with goods and services Medpace Holdings provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Medpace Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.As of 04/23/2024, Sales General And Administrative To Revenue is likely to grow to 0.12, while Selling General Administrative is likely to drop slightly above 95.9 M.

	2021	2022	2023	2024 (projected)
Gross Profit	328.2M	432.4M	524.5M	278.6M
Total Revenue	1.1B	1.5B	1.9B	2.0B

Gross Profit Total Revenue

Medpace Holdings fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets
Common Stock Shares Outstanding		-0.43	0.2	-0.24	-0.69	-0.03	0.26	0.16	-0.42	-0.69	0.25	0.52	-0.37	-0.12	-0.53	-0.7	-0.46	0.31	-0.12	-0.5	0.71	0.51	0.33	0.22	0.33	-0.43
Total Assets	-0.43		-0.39	0.06	0.79	0.54	-0.31	0.42	0.91	0.81	-0.69	-0.02	0.74	0.85	0.67	0.8	0.74	-0.5	0.85	0.81	-0.42	-0.32	-0.45	-0.42	-0.45	0.84
Short Long Term Debt Total	0.2	-0.39		-0.01	-0.58	-0.75	0.84	-0.8	-0.59	-0.58	0.9	0.04	-0.8	-0.44	0.31	-0.51	-0.51	0.98	-0.44	-0.67	0.35	-0.4	0.73	1.0	0.73	-0.69
Other Current Liab	-0.24	0.06	-0.01		0.34	-0.37	-0.12	-0.2	0.32	0.3	0.14	-0.71	0.32	-0.31	0.32	0.34	0.19	-0.13	-0.31	0.31	-0.01	-0.18	-0.11	-0.09	-0.11	0.38
Total Current Liabilities	-0.69	0.79	-0.58	0.34		0.38	-0.57	0.26	0.86	1.0	-0.68	-0.5	0.85	0.49	0.54	0.99	0.79	-0.71	0.49	0.89	-0.77	-0.43	-0.57	-0.62	-0.57	0.88
Total Stockholder Equity	-0.03	0.54	-0.75	-0.37	0.38		-0.56	0.92	0.5	0.4	-0.91	0.53	0.56	0.83	-0.19	0.35	0.47	-0.72	0.83	0.41	-0.22	0.46	-0.58	-0.73	-0.58	0.5
Other Liab	0.26	-0.31	0.84	-0.12	-0.57	-0.56		-0.58	-0.48	-0.57	0.74	0.2	-0.65	-0.31	0.23	-0.55	-0.34	0.86	-0.31	-0.57	0.45	-0.31	0.58	0.84	0.58	-0.58
Net Tangible Assets	0.16	0.42	-0.8	-0.2	0.26	0.92	-0.58		0.5	0.28	-0.86	0.49	0.61	0.7	-0.36	0.21	0.39	-0.75	0.7	0.42	0.06	0.63	-0.59	-0.79	-0.59	0.52
Property Plant And Equipment Net	-0.42	0.91	-0.59	0.32	0.86	0.5	-0.48	0.5		0.87	-0.74	-0.24	0.93	0.69	0.52	0.83	0.83	-0.7	0.69	0.94	-0.38	-0.21	-0.56	-0.63	-0.57	0.98
Current Deferred Revenue	-0.69	0.81	-0.58	0.3	1.0	0.4	-0.57	0.28	0.87		-0.7	-0.47	0.85	0.52	0.55	0.99	0.79	-0.71	0.52	0.89	-0.77	-0.43	-0.57	-0.62	-0.57	0.88
Net Debt	0.25	-0.69	0.9	0.14	-0.68	-0.91	0.74	-0.86	-0.74	-0.7		-0.16	-0.82	-0.78	0.03	-0.64	-0.66	0.91	-0.78	-0.72	0.43	-0.25	0.71	0.89	0.71	-0.76
Retained Earnings	0.52	-0.02	0.04	-0.71	-0.5	0.53	0.2	0.49	-0.24	-0.47	-0.16		-0.3	0.46	-0.36	-0.49	-0.23	0.15	0.46	-0.4	0.46	0.55	0.14	0.09	0.14	-0.32
Accounts Payable	-0.37	0.74	-0.8	0.32	0.85	0.56	-0.65	0.61	0.93	0.85	-0.82	-0.3		0.57	0.23	0.8	0.78	-0.88	0.57	0.95	-0.4	-0.05	-0.7	-0.84	-0.7	0.97
Cash	-0.12	0.85	-0.44	-0.31	0.49	0.83	-0.31	0.7	0.69	0.52	-0.78	0.46	0.57		0.31	0.5	0.57	-0.48	1.0	0.53	-0.22	0.06	-0.42	-0.44	-0.42	0.61
Non Current Assets Total	-0.53	0.67	0.31	0.32	0.54	-0.19	0.23	-0.36	0.52	0.55	0.03	-0.36	0.23	0.31		0.6	0.45	0.15	0.31	0.42	-0.38	-0.78	0.04	0.27	0.04	0.41
Non Currrent Assets Other	-0.7	0.8	-0.51	0.34	0.99	0.35	-0.55	0.21	0.83	0.99	-0.64	-0.49	0.8	0.5	0.6		0.71	-0.65	0.5	0.87	-0.77	-0.47	-0.54	-0.55	-0.54	0.86
Other Assets	-0.46	0.74	-0.51	0.19	0.79	0.47	-0.34	0.39	0.83	0.79	-0.66	-0.23	0.78	0.57	0.45	0.71		-0.62	0.57	0.72	-0.53	-0.25	-0.51	-0.54	-0.51	0.76
Long Term Debt	0.31	-0.5	0.98	-0.13	-0.71	-0.72	0.86	-0.75	-0.7	-0.71	0.91	0.15	-0.88	-0.48	0.15	-0.65	-0.62		-0.48	-0.77	0.44	-0.28	0.78	0.99	0.78	-0.79
Cash And Short Term Investments	-0.12	0.85	-0.44	-0.31	0.49	0.83	-0.31	0.7	0.69	0.52	-0.78	0.46	0.57	1.0	0.31	0.5	0.57	-0.48		0.53	-0.22	0.06	-0.42	-0.44	-0.42	0.61
Net Receivables	-0.5	0.81	-0.67	0.31	0.89	0.41	-0.57	0.42	0.94	0.89	-0.72	-0.4	0.95	0.53	0.42	0.87	0.72	-0.77	0.53		-0.46	-0.25	-0.62	-0.71	-0.62	0.97
Good Will	0.71	-0.42	0.35	-0.01	-0.77	-0.22	0.45	0.06	-0.38	-0.77	0.43	0.46	-0.4	-0.22	-0.38	-0.77	-0.53	0.44	-0.22	-0.46		0.5	0.31	0.35	0.31	-0.39
Common Stock Total Equity	0.51	-0.32	-0.4	-0.18	-0.43	0.46	-0.31	0.63	-0.21	-0.43	-0.25	0.55	-0.05	0.06	-0.78	-0.47	-0.25	-0.28	0.06	-0.25	0.5		-0.21	-0.37	-0.21	-0.16
Short Term Investments	0.33	-0.45	0.73	-0.11	-0.57	-0.58	0.58	-0.59	-0.56	-0.57	0.71	0.14	-0.7	-0.42	0.04	-0.54	-0.51	0.78	-0.42	-0.62	0.31	-0.21		0.74	1.0	-0.66
Non Current Liabilities Total	0.22	-0.42	1.0	-0.09	-0.62	-0.73	0.84	-0.79	-0.63	-0.62	0.89	0.09	-0.84	-0.44	0.27	-0.55	-0.54	0.99	-0.44	-0.71	0.35	-0.37	0.74		0.74	-0.73
Inventory	0.33	-0.45	0.73	-0.11	-0.57	-0.58	0.58	-0.59	-0.57	-0.57	0.71	0.14	-0.7	-0.42	0.04	-0.54	-0.51	0.78	-0.42	-0.62	0.31	-0.21	1.0	0.74		-0.66
Other Current Assets	-0.43	0.84	-0.69	0.38	0.88	0.5	-0.58	0.52	0.98	0.88	-0.76	-0.32	0.97	0.61	0.41	0.86	0.76	-0.79	0.61	0.97	-0.39	-0.16	-0.66	-0.73	-0.66

Click cells to compare fundamentals

Medpace Holdings Account Relationship Matchups

Medpace Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	37.6M	37.7M	37.7M	33.7M	31.8M	29.1M
Total Assets	1.1B	1.4B	1.7B	1.4B	1.7B	1.3B
Short Long Term Debt Total	45.2M	115.1M	131.0M	188.9M	142.1M	156.5M
Other Current Liab	19.0M	23.5M	27.6M	257.7M	40.4M	70.6M
Total Current Liabilities	343.0M	440.1M	557.2M	803.5M	925.1M	971.4M
Total Stockholder Equity	726.3M	805.8M	952.9M	386.4M	559.0M	654.5M
Other Liab	28.6M	29.6M	18.8M	23.8M	21.4M	20.0M
Net Tangible Assets	9.5M	96.9M	249.2M	(314.0M)	(361.1M)	(379.2M)
Property Plant And Equipment Net	99.4M	198.8M	222.7M	248.9M	265.4M	138.1M
Current Deferred Revenue	192.4M	255.7M	344.6M	462.7M	559.9M	587.9M
Net Debt	(86.7M)	(162.6M)	(330.3M)	160.6M	(103.3M)	(98.2M)
Retained Earnings	68.1M	115.2M	235.0M	(359.8M)	(221.6M)	(210.6M)
Accounts Payable	22.4M	26.6M	25.7M	33.1M	31.9M	21.9M
Cash	131.9M	277.8M	461.3M	28.3M	245.4M	143.1M
Non Current Assets Total	826.0M	917.0M	969.0M	1.0B	1.1B	1.0B
Non Currrent Assets Other	9.5M	8.8M	17.4M	21.1M	25.0M	26.2M
Other Assets	9.9M	123.1M	42.6M	69.2M	79.6M	83.6M
Cash And Short Term Investments	131.9M	277.8M	461.3M	28.3M	245.4M	143.1M
Net Receivables	155.7M	161.0M	186.4M	253.4M	298.4M	163.0M
Common Stock Total Equity	355K	356K	360K	309K	278.1K	279.2K
Liabilities And Stockholders Equity	1.1B	1.4B	1.7B	1.4B	1.7B	1.3B
Non Current Liabilities Total	73.8M	144.8M	149.8M	162.6M	172.7M	182.2M
Other Current Assets	29.4M	34.9M	43.2M	52.3M	50.0M	32.1M
Other Stockholder Equity	660.6M	690.3M	722.4M	758.3M	790.4M	699.5M
Total Liab	416.8M	584.9M	707.0M	966.1M	1.1B	685.5M
Deferred Long Term Liab	12.8M	13.6M	1.1M	1.1M	1.2M	1.2M
Property Plant And Equipment Gross	99.4M	198.8M	222.7M	248.9M	344.8M	362.0M
Total Current Assets	317.0M	473.7M	690.9M	334.0M	593.8M	338.7M
Accumulated Other Comprehensive Income	(2.7M)	(131K)	(4.8M)	(12.4M)	(10.1M)	(9.6M)
Short Term Debt	109.3M	134.4M	159.3M	50M	293.0M	307.6M
Intangible Assets	54.4M	46.5M	41.4M	38.0M	35.8M	34.0M
Common Stock	355K	356K	360K	309K	308K	275.9K
Property Plant Equipment	99.4M	85.0M	93.2M	109.8M	126.3M	74.3M
Capital Surpluse	666.6M	695.9M	727.9M	770.8M	886.4M	714.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medpace Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medpace Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medpace Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Medpace Holdings Stock:

How To Invest In Medpace

Details

Is Medpace Stock a good investment?

Details

What is Medpace Holdings' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Medpace Stock analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.

	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Technical Analysis Check basic technical indicators and analysis based on most latest market data

Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.165

Earnings Share

8.9

Revenue Per Share

61.384

Quarterly Revenue Growth

0.265

Return On Assets

0.1399

The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medpace Interest Expense vs Cost of Revenue Analysis

Interest Expense vs Cost Of Revenue

Interest Expense vs Cost of Revenue Correlation Analysis

Correlation Coefficient

Interest Expense

Cost Of Revenue

Medpace Holdings fundamental ratios Correlations

Medpace Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medpace Holdings fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Medpace Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Current Deferred Revenue	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 1.0	Short Term Investments
Non Currrent Assets Other	+ 0.99	Total Current Liabilities
Non Currrent Assets Other	+ 0.99	Current Deferred Revenue

Net Debt	- 0.91	Total Stockholder Equity
Long Term Debt	- 0.88	Accounts Payable
Net Debt	- 0.86	Net Tangible Assets
Non Current Liabilities Total	- 0.84	Accounts Payable
Accounts Payable	- 0.82	Net Debt
Accounts Payable	- 0.8	Short Long Term Debt Total